References
- Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010;10:849-59. https://doi.org/10.1038/nri2889
- Ochs HD, Gambineri E, Torgerson TR. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007;38:112-21. https://doi.org/10.1007/s12026-007-0022-2
- Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-87. https://doi.org/10.1016/j.cell.2008.05.009
- Yazdanbakhsh K, Zhong H, Bao W. Immune dysregulation in immune thrombocytopenia. Semin Hematol 2013;50 Suppl 1:S63-7. https://doi.org/10.1053/j.seminhematol.2013.03.011
- Cuker A, Cines DB. Immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2010;2010:377-84. https://doi.org/10.1182/asheducation-2010.1.377
- Imbach P, Kuhne T, Muller D, Berchtold W, Zimmerman S, Elalfy M, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006;46:351-6.. https://doi.org/10.1002/pbc.20453
- Bennett CM, Tarantino M. Chronic immune thrombocytopenia in children: epidemiology and clinical presentation. Hematol Oncol Clin North Am 2009;23:1223-38. https://doi.org/10.1016/j.hoc.2009.08.002
- Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008. https://doi.org/10.1056/NEJMra010501
- Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 2008;99:4-13.
- Lazarus AH, Semple JW, Cines DB. Innate and adaptive immunity in immune thrombocytopenia. Semin Hematol 2013;50 Suppl 1:S68-70. https://doi.org/10.1053/j.seminhematol.2013.03.012
- Johnsen J. Pathogenesis in immune thrombocytopenia: new insights. Hematology Am Soc Hematol Educ Program 2012;2012:306-12.
- Rosthoj S, Rajantie J, Treutiger I, Zeller B, Tedgard U, Henter JI, et al. Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort. Acta Paediatr 2012;101:761-6. https://doi.org/10.1111/j.1651-2227.2012.02671.x
- Heitink-Polle KM, Nijsten J, Boonacker CW, de Haas M, Bruin MC. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis. Blood 2014;124:3295-307. https://doi.org/10.1182/blood-2014-04-570127
- Jayabose S, Levendoglu-Tugal O, Ozkaynkak MF, Visintainer P, Sandoval C. Long-term outcome of chronic idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2004;26:724-6. https://doi.org/10.1097/00043426-200411000-00007
- Yacobovich J, Revel-Vilk S, Tamary H. Childhood immune thrombocytopenia: who will spontaneously recover? Semin Hematol 2013;50 Suppl 1:S71-4. https://doi.org/10.1053/j.seminhematol.2013.03.013
- Andersson PO, Stockelberg D, Jacobsson S, Wadenvik H. A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol 2000;79:507-13. https://doi.org/10.1007/s002770000177
- Shim YJ, Kim UH, Suh JK, Lee KS. Natural course of childhood chronic immune thrombocytopenia using the revised terminology and definitions of the international working group: a single center experience. Blood Res 2014;49:187-91. https://doi.org/10.5045/br.2014.49.3.187
- Godeau B. Immune thrombocytopenic purpura: major progress in knowledge of the pathophysiology and the therapeutic strategy, but still a lot of issues. Presse Med 2014;43(4 Pt 2):e47-8. https://doi.org/10.1016/j.lpm.2014.02.010
- Nishimoto T, Kuwana M. CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia. Semin Hematol 2013;50 Suppl 1:S43-9. https://doi.org/10.1053/j.seminhematol.2013.03.018
- Olsson B, Andersson PO, Jernas M, Jacobsson S, Carlsson B, Carlsson LM, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003;9:1123-4. https://doi.org/10.1038/nm921
- Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-86. https://doi.org/10.1182/blood-2009-06-225565
- Michel M. Immune thrombocytopenia nomenclature, consensus reports, and guidelines: what are the consequences for daily practice and clinical research? Semin Hematol 2013;50 Suppl 1:S50-4. https://doi.org/10.1053/j.seminhematol.2013.03.008
- Ruggeri M, Fortuna S, Rodeghiero F. Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature. Haematologica 2008;93:98-103. https://doi.org/10.3324/haematol.11582
Cited by
- Prognostic Significance of IL-10 in Childhood Chronic Immune Thrombocytopenic Purpura vol.23, pp.1, 2016, https://doi.org/10.15264/cpho.2016.23.1.28
- Clinical Course of Childhood Immune Thrombocytopenic Purpura and Analysis Predicting Factor of Prognosis vol.24, pp.2, 2015, https://doi.org/10.15264/cpho.2017.24.2.88
- Low-dose chidamide restores immune tolerance in ITP in mice and humans vol.133, pp.7, 2015, https://doi.org/10.1182/blood-2018-05-847624
- Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia vol.26, pp.1, 2021, https://doi.org/10.1080/16078454.2020.1856511